XML 81 R62.htm IDEA: XBRL DOCUMENT v3.25.1
Debt (Details Narrative) - USD ($)
May 30, 2024
Dec. 31, 2024
Dec. 31, 2023
Debt Instrument [Line Items]      
Final fee   $ 4,500,000
Warrants issued   11,268,939  
Amended and Restated Loan Agreement [Member]      
Debt Instrument [Line Items]      
Debt instrument interest rate description the Company is entitled to make interest-only payments for thirty-six months, or up to forty-eight months if certain conditions are met. The Term Loans will mature on May 1, 2029 and will bear interest at a rate equal to the sum of (a) the greater of (i) the Prime Rate (as defined in the A&R Loan Agreement) or (ii) 7.75%, plus (b) 2.85%, provided that 1.0% of such interest will be payable in-kind by adding an amount equal to such 1.0% of the outstanding principal amount to the then outstanding principal balance on a monthly basis through May 31, 2027.    
Maximum [Member]      
Debt Instrument [Line Items]      
Warrants exercise price per share   $ 9.50  
Amended and Restated Loan Agreement [Member] | Innovatus Life Sciences [Member]      
Debt Instrument [Line Items]      
Funded loan amount $ 100    
Costs associated with new borrowings $ 2,400,000    
Final fee percentage 4.50%    
Final fee $ 4,500,000    
Warrant or right, reason for issuance, description 2.50%    
Amended and Restated Loan Agreement [Member] | Innovatus Life Sciences [Member] | Warrant [Member]      
Debt Instrument [Line Items]      
Warrants issued 103,876    
Warrants exercise price per share $ 14.84    
Fair value of warrants $ 1,200,000    
Amended and Restated Loan Agreement [Member] | Innovatus Life Sciences [Member] | Term A Loan [Member]      
Debt Instrument [Line Items]      
Funded loan amount $ 16,800,000    
Loan conversion percentage 20.00%    
Common stock price per share $ 10.00    
Amended and Restated Loan Agreement [Member] | Innovatus Life Sciences [Member] | Term B Loan [Member]      
Debt Instrument [Line Items]      
Funded loan amount $ 21,500,000    
Amended and Restated Loan Agreement [Member] | Innovatus Life Sciences [Member] | Term C Loan [Member]      
Debt Instrument [Line Items]      
Funded loan amount 61,700,000    
Amended and Restated Loan Agreement [Member] | Innovatus Life Sciences [Member] | Term D Loan [Member]      
Debt Instrument [Line Items]      
Funded loan amount 30,000,000    
Non utilization fee 900,000    
Amended and Restated Loan Agreement [Member] | Innovatus Life Sciences [Member] | Term E Loan [Member]      
Debt Instrument [Line Items]      
Funded loan amount 50,000,000    
Non utilization fee 1,500,000    
Amended and Restated Loan Agreement [Member] | Innovatus Life Sciences [Member] | Term F Loan [Member]      
Debt Instrument [Line Items]      
Funded loan amount 45,000,000    
Amended and Restated Loan Agreement [Member] | Innovatus Life Sciences [Member] | Maximum [Member]      
Debt Instrument [Line Items]      
Funded contingent loan, outstanding $ 180,000,000    
Prior Loan Agreement [Member] | Innovatus Life Sciences [Member]      
Debt Instrument [Line Items]      
Common stock price per share $ 14.40    
Common stock issued 26,042